Drug Trial Radar · NCT01435928
PEARL Schizophrenia Maintenance
Last checked: Nov 20, 2026Latest source record: Apr 8, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
676
Actual
Start
Sep 2011
Primary completion
Aug 2013
Study completion Aug 2013
Sponsor
- Lead sponsor
- Sumitomo Pharma America, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 19, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Lurasidone HCI is a compound that is FDA-approved for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that Lurasidone is effective in the long term maintenance treatment of schizophrenia.
Conditions
- Schizophrenia
Interventions
LurasidoneDrug
Lurasidone 40 and 80 mg, once daily in the evening with a meal or 30 minutes after eating
Matching PlaceboDrug
Matching placebo once daily in the evening with a meal or 30 minutes after eating
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Relapse Event During Double-blind PhaseTime frame: Double-blind phase - 28 Weeks
Locations
75 sites in 7 countries. Site status is shown where the registry gives one.
Woodland Research Northwest
Springdale, Arizona
K&S Professional Research
Little Rock, Arkansas
Woodland International Research Group
Little Rock, Arkansas
Comprehensive Clinical Development Inc.
Cerritos, California
Diligent Clinical Trials
Downey, California
Synergy Escondido
Escondido, California
Collaborative Neuroscience Network, Inc.
Garden Grove, California
Axis Clinical Trials
Los Angeles, California
Synergy Clinical Research Center
National City, California
Excell Clinical Trials
Oceanside, California
CNRI - Los Angeles LLC,8309 Telegraph Road
Pico Rivera, California
California Neuropsychopharmacology Clinical Research Instit
San Diego, California
Neuropsychiatric Research Center of Orange County
Santa Ana, California
Collaborative Neuroscience Network Inc.
Torrance, California
Florida Clinical Research Center, LLC
Bradenton, Florida
Accurate Clinical Trials
Kissimme, Florida
Florida Clinical Research Center, LLC
Maitland, Florida
Galiz Research
Miami Springs, Florida
Medical Research Group of Central Florida
Orange City, Florida
Atlanta Center for Medical Research
Atlanta, Georgia
Comprehensive NeuroScience, Inc.
Atlanta, Georgia
Lake Charles Clinical Trials
Lake Charles, Louisiana
Lousiana Clinical Research, LLC
Shreveport, Louisiana
CBH Health LLC
Rockville, Maryland
Psychiatric Care and Research Center
O'Fallon, Missouri
Psych Care Consultants Research
St Louis, Missouri
Horne Research
Las Vegas, Nevada
Center for Psychiatry and Behavioral Medicine, Inc.
Las Vegas, Nevada
CRI Worldwide LLC
Willingboro, New Jersey
University of New York, Dept. of Psychiatry
Buffalo, New York
Neurobehavioral Research, Inc.
Cedarhurst, New York
Comprehensive Clinical Development, Inc
Fresh Meadows, New York
Finger Lakes Clinical Research
Rochester, New York
Behavioral Medical Research of Staten Island
Staten Island, New York
Cutting Edge Research Group
Oklahoma City, Oklahoma
Oklahoma Clinical Research
Oklahoma City, Oklahoma
CRI Worldwide LLC at Kirkbride
Philadelphia, Pennsylvania
Lincoln Research
Lincoln, Rhode Island
Community Clinical Research, Inc.
Austin, Texas
FutureSearch Clinical Trials LP
Austin, Texas
Showing 40 of 75 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.